539. GS-CA2: A Novel, Potent, and Selective First-In-class Inhibitor of HIV-1 Capsid Function Displays Nonclinical Pharmacokinetics Supporting Long-Acting Potential in Humans

Saved in:
Bibliographic Details
Published inOpen forum infectious diseases Vol. 5; no. suppl_1; pp. S199 - S200
Main Authors Zheng, Jim, Yant, Stephen R, Ahmadyar, Shekeba, Chan, Tiffany Y, Chiu, Anna, Cihlar, Tomas, Link, John O, Lu, Bing, Mwangi, Judy, Rowe, William, Schroeder, Scott D, Stepan, George J, Wang, Kelly Wei, Subramanian, Raju, Tse, Winston C
Format Journal Article
LanguageEnglish
Published US Oxford University Press 26.11.2018
Subjects
Abstracts
Online AccessGet full text

Cover

More Information
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofy210.548